Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study (Q51607498)

8 April 2018

title

Low-density lipoprotein cholesterol and the risk of cancer: a mendelian randomization study (English)

1 reference

8 April 2018

1 reference

1 reference

8 April 2018

Stefan Stender

0 references

Anne Tybjærg-Hansen

1 reference

8 April 2018

Børge G. Nordestgaard

series ordinal

object named as

Børge G Nordestgaard

1 reference

8 April 2018

Ruth Frikke-Schmidt

1 reference

8 April 2018

language of work or name

English

0 references

publication date

1 February 2011

1 reference

8 April 2018

Journal of the National Cancer Institute

published in

1 reference

8 April 2018

volume

103

1 reference

8 April 2018

issue

1 reference

8 April 2018

page(s)

508-519

1 reference

8 April 2018

Colon cancer and blood-cholesterol.

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172,210 men and women: a prospective 19-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

Report of the Conference on Low Blood Cholesterol: Mortality Associations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

Analyses of cancer data from three ezetimibe trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

Carcinogenicity of lipid-lowering drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

Bayesian methods for meta-analysis of causal relationships estimated using genetic instrumental variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

Mendelian randomization: prospects, potentials, and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

Adjusting for bias and unmeasured confounding in Mendelian randomization studies with binary responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

Mendelian randomization: nature's randomized trial in the post-genome era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

Genetically elevated C-reactive protein and ischemic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

Completeness of cancer registration in Denmark 1943-1966 and efficacy of record linkage procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

Apolipoprotein E genotype: epsilon32 women are protected while epsilon43 and epsilon44 men are susceptible to ischemic heart disease: the Copenhagen City Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

Underestimation of Risk Associations Due to Regression Dilution in Long-term Follow-up of Prospective Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

Interaction revisited: the difference between two estimates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

At sea with SEAS: the first clinical endpoint trial for ezetimibe, treatment of patients with mild to moderate aortic stenosis, ends with mixed results and more controversy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

Sequence variation in proprotein convertase subtilisin/kexin type 9 serine protease gene, low LDL cholesterol, and cancer incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

Apolipoprotein e genotype, plasma cholesterol, and cancer: a Mendelian randomization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

Biological, clinical and population relevance of 95 loci for blood lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

Association of mutations in the apolipoprotein B gene with hypercholesterolemia and the risk of ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

ApoE genotype: impact on health, fitness and nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR008

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJR008

1 reference

8 April 2018

release_xkc7n3qqijhxvc5fn4zpr7xazq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xkc7n3qqijhxvc5fn4zpr7xazq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

8 April 2018